RaySearch Laboratories AB (publ) Year-end Report 2007

RaySearch Laboratories AB (publ) Year-end Report 2007

JANUARY 1 - DECEMBER 31, 2007 
• Net sales for the period amounted to SEK 64.7 M (69.0)
• Profit after tax was SEK 19.8 M (36.2)
• Earnings per share after tax amounted to SEK 1.73 (3.17)
• Operating profit amounted to SEK 25.8 M (33.5)
• Cash flow from operating activities amounted to SEK 37.9 M (30.1)
• Collaboration agreement with Varian Medical Systems was signed in May
• Collaboration agreement with TomoTherapy was signed in August
• COMPASS® received FDA clearance and was launched in December.
• Board of Directors proposes a dividend of SEK 0.50 (0.00) per share
• Board of Directors proposes 3:1 share split

”We are now in a phase of intensive development. During 2007 we expanded from
three to five partners and increased the number of employees in research and
development by three quarters. In December, we also entered an entirely new
market segment with the launch of COMPASS®,” says Johan Löf, CEO of RaySearch.

“Financially, 2007 was a moderate year since the new products and partnerships
had not yet begun to contribute to earnings positively. But with eight products
on the market and more than fifteen new products in development, the conditions
for solid growth are favorable. I am therefore highly optimistic about the
future,” concludes Johan Löf.


FOR FURTHER INFORMATION, CONTACT:

Johan Löf, President and CEO
Telephone: +46 (0)8-545 061 30
johan.lof@raysearchlabs.com

RaySearch Laboratories AB (publ)
Corp. Reg. No. 556322-6157
Sveavägen 25
SE-111 34 Stockholm 

ABOUT RAYSEARCH

RaySearch Laboratories is a medical technology company that develops advanced
software solutions for improved radiation therapy of cancer. RaySearch's
products are sold through license agreements with leading partners such as
Philips, Varian, Nucletron, IBA Dosimetry and TomoTherapy. Eight products have
been released to date and RaySearch's software is used at over 1,200 clinics in
more than 30 countries. In addition, existing license agreements cover more than
15 other products that are scheduled to be launched in the coming years.
RaySearch was founded in 2000 as a spin-off from Karolinska Institutet in
Stockholm and the company is listed in the SmallCap segment on the OMX Nordic
Exchange Stockholm. 

For more information about RaySearch, visit www.raysearchlabs.com.